P-027 Clinical efficacy of oral bepridil for persistent atrial fibrillation.

MLA

Nakazato, Y., et al. “P-027 Clinical Efficacy of Oral Bepridil for Persistent Atrial Fibrillation.” EP: Europace, vol. 4, no. Supplement_2, Dec. 2002, p. B73. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=90325288&authtype=sso&custid=ns315887.

APA

Nakazato, Y., Sasaki, A., Yamashita, H., Kawano, Y., Iida, Y., Mineda, Y., Nakazato, K., Yasuda, M., Tokano, T., Sumiyoshi, M., Nakata, Y., & Daida, H. (2002). P-027 Clinical efficacy of oral bepridil for persistent atrial fibrillation. EP: Europace, 4(Supplement_2), B73.

Chicago

Nakazato, Y., A. Sasaki, H. Yamashita, Y. Kawano, Y. Iida, Y. Mineda, K. Nakazato, et al. 2002. “P-027 Clinical Efficacy of Oral Bepridil for Persistent Atrial Fibrillation.” EP: Europace 4 (Supplement_2): B73. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=90325288&authtype=sso&custid=ns315887.